Department of Molecular Biology in Medicine, Civil Hospital of Guadalajara Fray Antonio Alcalde and University of Guadalajara, Guadalajara, Jalisco, Mexico.
Ann Hepatol. 2012 Mar-Apr;11(2):194-201.
Viral hepatitis in children is a major public health problem worldwide.
To evaluate the prevalence of serological markers for hepatitis A, B and C infections in Mexican children diagnosed with hepatitis during a five-year period.
A total of 31,818 children admitted to a tertiary level hospital in Mexico from 2005 to 2009 were evaluated for hepatitis.
Hepatitis was found in 215 (0.7%) of the children. Serum samples from hepatitis-positive children were screened for anti-HAV IgM, HBsAg, total anti-HBc and anti-HCV. HAV was the leading cause of viral hepatitis (81%), followed by HBV and HCV (3.1 and 2%, respectively), whereas no serological marker was observed in 13.9% of the analyzed samples. Furthermore, when children were categorized by age, a significant increase in anti-HAV detection was observed in school-aged children (7-11 years old) (p < 0.001) and a reduction in adolescents (12-15 years old).
In conclusion, hepatitis A is the most prevalent viral hepatitis infection detected in children, followed by HBV and HCV. In addition, the high percentage of hepatitis infections without a known etiological agent and the serological test limitations require the detection of occult HBV, HCV and hepatitis E infections. The age-dependent vulnerability of groups with HAV infections emphasizes the importance of HAV vaccination in young children in Mexico.
儿童病毒性肝炎是全球一个主要的公共卫生问题。
评估在五年期间,墨西哥被诊断为肝炎的儿童中,甲型、乙型和丙型肝炎感染的血清标志物流行率。
对 2005 年至 2009 年期间在墨西哥一家三级医院就诊的 31818 名儿童进行了肝炎评估。
在 215 名(0.7%)儿童中发现了肝炎。对肝炎阳性儿童的血清样本进行了抗-HAV IgM、HBsAg、总抗-HBc 和抗-HCV 检测。甲型肝炎病毒(HAV)是病毒性肝炎的主要病因(81%),其次是乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)(分别为 3.1%和 2%),而在分析的样本中,有 13.9%未观察到血清学标志物。此外,当按年龄对儿童进行分类时,在学龄儿童(7-11 岁)中观察到抗-HAV 检测显著增加(p < 0.001),而青少年(12-15 岁)则减少。
总之,甲型肝炎是儿童中最常见的病毒性肝炎感染,其次是乙型肝炎和丙型肝炎。此外,由于未知病因的肝炎感染比例较高,且血清学检测存在局限性,需要检测隐匿性乙型肝炎、丙型肝炎和戊型肝炎感染。具有 HAV 感染的人群的年龄依赖性易感性强调了在墨西哥为幼儿接种 HAV 疫苗的重要性。